FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

444773003: Velaglucerase alfa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2869587011 Velaglucerase alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2872904013 Velaglucerase alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1861411000195117 velaglucerasi alfa it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
19191000188114 vélaglucérase alfa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
849081000172117 vélaglucérase alpha fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
403021000274111 Velaglucerase Alpha de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Velaglucerase alfa (substance) Is a Glucosylceramidase true Inferred relationship Some
Velaglucerase alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Velaglucerase alfa (substance) Inferred relationship Some
Velaglucerase alfa 200unit lyophilized powder for injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Velaglucerase alfa (substance) Inferred relationship Some
Product containing velaglucerase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing only velaglucerase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing velaglucerase alfa in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Velaglucerase alfa (substance) Inferred relationship Some 1
Velaglucerase alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Velaglucerase alfa (substance) Inferred relationship Some 1
Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Velaglucerase alfa (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start